**Wales Announces Strip-Back Covid Vaccine Rollout for Autumn: Who Will Be Eligible?**
As Wales prepares for its latest Covid-19 vaccination campaign this autumn, significant alterations have been made regarding who qualifies for a jab. Officials say the updated approach reflects the shifting landscape of the pandemic, with immunity amongst the population now far higher than in previous years. However, the virus continues to circulate, and health authorities are targeting resources at those who remain most vulnerable.
Speaking earlier this week, Jeremy Miles MS, the cabinet secretary for health and social care in Wales, unveiled the revised eligibility list for both the autumn 2025 and spring 2026 vaccine rounds. The announcement follows guidance from the Joint Committee on Vaccination and Immunisation (JCVI), a body responsible for advising the UK and devolved governments on vaccine programmes.
Mr Miles stated: “Eligibility for the autumn 2025 Covid-19 programme will be narrower than in recent years, echoing the current spring scheme. We are continuing the transition to a more focused rollout, as naturally acquired and vaccine-derived immunity has risen dramatically over the past four and a half years.”
With hospitalisation and mortality rates now far lower for much of the community, the Welsh government has prioritised those who are statistically at greater risk of serious illness. This decision comes after a comprehensive JCVI review, which considered not just the state of the pandemic but new research and evidence about vaccine effectiveness among different groups.
According to the latest guidance, this autumn’s Covid vaccine will be made available to the following groups in Wales:
– Residents living in older adult care homes
– Anyone aged 75 or above
– Individuals aged six months to 64 years who belong to clinical risk categories due to specific health conditions (especially immunosuppression)
The clinical risk category primarily refers to people with weakened immune systems, including those:
– Undergoing chemotherapy that reduces immunity
– Receiving radical radiotherapy
– Who have had organ, bone marrow or stem cell transplants
– Living with HIV at any stage
– Diagnosed with certain genetic disorders affecting immune function (examples include IRAK-4, NEMO, complement disorder, or severe combined immunodeficiency)
– On immunosuppressive or immunomodulating therapies, including but not limited to anti-TNF, alemtuzumab, ofatumumab, rituximab, and protein kinase inhibitors or PARP inhibitors
– Using steroid-sparing medicines such as cyclophosphamide and mycophenolate mofetil
– Receiving longer-term courses of high-dose steroids
– With histories of blood cancers, such as leukaemia, lymphoma, or myeloma
– Requiring persistent immunosuppressive medications for chronic conditions like lupus, rheumatoid arthritis, inflammatory bowel disease, scleroderma or psoriasis
Recent statistics indicate that while Covid-19 now presents as a mild illness for most people in Wales, it still poses a grave threat to the elderly and those with compromised immune systems. Hospital admissions and fatalities, though significantly reduced since the early days of the pandemic, remain disproportionately weighted towards these groups.
The JCVI’s review emphasises an increasingly standardised approach across the UK, suggesting a move towards considering cost-effectiveness for mass vaccination efforts. As Covid transitions from pandemic to endemic status, mass immunisation for all adults is no longer recommended. Instead, resources will focus almost exclusively on those with the greatest risk of severe outcomes.
Welsh health authorities are advising those who fall into the now tighter eligibility groups to take up the invitation for vaccination when contacted. Meanwhile, the general population are encouraged to remain vigilant but assured that current levels of natural and vaccine-induced resistance offer robust protection for the majority.
The upcoming vaccination campaign forms part of a broader NHS Wales strategy, aiming to ensure healthcare resources are effectively channelled while also maintaining readiness for potential future surges or variant-driven outbreaks.
Further information about the autumn campaign, including how and when eligible individuals can schedule their vaccination, will be disseminated by the NHS and local health boards over the coming months. Those who believe they may qualify are advised to consult their GP or local health authorities for clarification and advice.